Cardiac transplantation is a well-established therapy for end-stage heart disease, though its long-term success is primarily limited by graft atherosclerosis and high costs.
No takes yet. Share an insight, caveat, or question.
Highlights transplant limitations in atherosclerosis and costs; leaves open targeted prevention and affordability research.
Argenziano et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: